Adar Biotech

Company Overview

Snapshot

Founded in March 2006 by Yinon Shlomi, Adar Biotech operates with 1–10 employees. The company specializes in developing miniature medical devices for enhanced drug delivery and homeland security applications, alongside providing research services.

Business overview

Adar Biotech develops miniature medical devices designed to enhance drug delivery and for homeland security/bioterrorism applications. The company also offers products and services to the research community, including the manufacture of functional resins and recombinant proteins, and immunological and cell-culture services. Adar Biotech specializes in generating monoclonal antibodies to challenging antigens, serving markets in Health Tech & Life Sciences, particularly in Pharma & Medical Biotechnology and Medical Devices.

Company Intelligence Q&A

What is Adar Biotech's primary focus?

Adar Biotech primarily focuses on developing miniature medical devices for enhancing drug delivery and for homeland security/bioterrorism applications.

What research services does Adar Biotech provide?

Adar Biotech provides products and services to the research community, including the manufacture of functional resins and recombinant proteins, and immunological and cell-culture services.

Who founded Adar Biotech?

Adar Biotech was founded by Yinon Shlomi in March 2006.

In which sectors does Adar Biotech operate?

Adar Biotech operates within the Health Tech & Life Sciences sector, with specializations in Pharma & Medical Biotechnology and Medical Devices.

What is Adar Biotech's expertise in immunology?

Adar Biotech specializes in the generation of monoclonal antibodies to weak and difficult antigens, offering an immunology licensing package that includes an adjuvant, selection media, and screening technology.